ISPAD Sponsor and Exhibitor Guide 40 TH ANNIVERSARY. Diversity in Diabetes

Transcription

1 40 TH ANNUAL CONFERENCE International Society for Pediatric and Adolescent Diabetes ISPAD TH ANNIVERSARY September 3 rd 6 th, 2014 Toronto, Canada Diversity in Diabetes Sponsor and Exhibitor Guide

2 Diversity in Diabetes Table of Contents Table of Contents Conference Sponsors...3 Industry Satellite Symposia Program Overview Industry Satellite Symposia Exhibition Overview...13 Exhibitor Profiles

3 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Conference Sponsors ISPAD and the organizers would like to thank the following sponsors of the ISPAD 2014 conference: Gold Sponsors Silver Sponsors 3

4 INDUSTRY PROGRAM

5

6 Diversity in Diabetes page Scientific content Program Overview Wednesday, September 3, 2014 Grand Ballroom East Large Grand Ballroom Centre Grand Ballroom West Presidents Welcome Opening Lecture Plenary Session I Challenges and Opportunities in Diabetes Care Coffee Break Exhibition Area Symposium III Is Diabetes a Trauma? Symposium II ESPE/ISPAD Joint Symposium: Endocrine Autoimmunity: Mechanisms and Consequences of Autoimmune Conditions Symposium I From Clinical Trials to Practice: When Rubber Hits the Road Lunch Break Exhibition Area INDUSTRY SESSION Bayer Satellite Symposium Using accurate self-blood glucose monitoring systems to manage insulin treated diabetes in children and adolescents (p. 10) Novo Nordisk Satellite Symposium Childhood diabetes in developing countries: delivering care with impact (p. 10) Exhibition Poster Tours Oral Session I Diabetes Acute and Chronic Complications Oral Session II Exercise Obesity and Type 1 DM & Type 2 DM Oral Session III Diabetes Projects in Developing Countries Coffee Break Exhibition Area Opening Ceremony Opening Reception - Exhibition Area Please note that program changes may occur.

7 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Scientific Program page Overview content Thursday, September 4, 2014 Grand Ballroom East Large Grand Ballroom Centre Grand Ballroom West Pine - Mezzanine Level Roche Satellite Symposium Children and Diabetes Technology a Challenging Constellation? (p. 11) INDUSTRY SESSION Plenary Session II Cultural Diversity 101: Providing Optimal Care in a Multi-Ethnic World Coffee Break Exhibition Area Oral Session IV Diabetes Genetics and Immunology Oral Session V Diabetes Education Oral Session VI Diabetes and Adolescence Sanofi Diabetes Lunch Break Satellite Symposium Modifying the course of Type Exhibition Area 1 Diabetes in young people: opportunities for change (p. 11) INDUSTRY SESSION Lunch Break Exhibition Area Exhibition Poster Tours Symposium IV Meet the Experts 1 Symposium V Early Detection of Kidney and Eye Disease in Type 1 Diabetes: Current Knowledge and Future Direction Symposium VI Putting Mindfulness in Diabetes Care INDUSTRY SESSION Eli Lilly Satellite Symposium Aptitudes and attitudes for a successful transition of care (p. 12) Coffee Break Exhibition Area INDUSTRY SESSION Dexcom Technology Workshop Practical Experience with Real Time Continuous Glucose Monitoring (Limited numbers only) (p. 12) ISPAD Speakers' Dinner (invitation only) 7

8 Diversity in Diabetes Scientific Program Overview Friday, September 5, 2014 Grand Ballroom East Large Grand Ballroom Centre Grand Ballroom West Plenary Session III Environmental Influence on Diabetes Risk Coffee Break Exhibition Area Oral Session IX Regimen-Based Innovations Oral Session VII Diabetes Epidemiology Oral Session VIII Psychosocial Issues in Diabetes Medtronic Lunch Break Exhibition Area INDUSTRY SESSION Satellite Symposium Impact of Sensor Augmented Pumps in real life to optimize patient s outcomes (p. 12) Lunch Break Exhibition Area Exhibition Poster Tours Symposium IX JDRF Symposium: High Incidence and High Risk Populations Symposium VIII Striving for Excellence in Diabetes Education Symposium VII Exercise: Benefits and Risks ISPAD Annual General Meeting ISPAD Members Only ISPAD Recognition Dinner Dominion Ballroom, Sheraton Centre Toronto until midnight 8

9 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Scientific Program Overview Saturday, September 6, 2014 Grand Ballroom East Large Grand Ballroom Centre Grand Ballroom West Plenary Session IV Food Diversity and Child Health Symposium X Debate: Is New Technology Improving Diabetes Care in Children and Adolescents Symposium XII Meet the Experts 2 Symposium XI VIDIS Symposium Plenary Session V Societal Impact of Diabetes Coffee Break Exhibition Area Exhibition Closing Ceremony Lunch Break Exhibition Area

10 Diversity in Diabetes Industry Satellite Symposia Wednesday, September 3, 2014 Bayer HealthCare Satellite Symposium Grand Ballroom Centre, 12:45 13:45 Novo Nordisk Satellite Symposium Grand Ballroom West, 12:45 13:45 Using accurate self-blood glucose monitoring systems to manage insulin treated diabetes in children and adolescents Chair: Henk Veeze (Netherlands) Evolution of SMBG over time enabled intensive glucose control and pump therapy New tighter accuracy requirements for medical devices and implications for diabetes care Childhood diabetes in developing countries: delivering care with impact Chair: Carine de Beaufort (Luxembourg) Welcome Carine de Beaufort (Luxembourg) Introduction to the Changing Diabetes in Children (CDiC) programme Ulrik Uldall Nielsen (Denmark) Importance of accurate readings in closed loop communications networks CDiC programme in action: spotlight on Tanzania Edna Majaliwa (Tanzania) Helping children and adolescents reduce the risk of hyper- and hypoglycemia CDiC programme in action: spotlight on Cameroon Susanne Sap Ngo Um (Cameroon) Primary challenges of management of childhood diabetes: mortality: why? what proposed solutions Discussion Closing remarks Carine de Beaufort (Luxembourg) 10

11 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Industry Satellite Symposia Thursday, September 4, 2014 Roche Satellite Symposium Grand Ballroom West, 07:45 08:45 Sanofi Diabetes Satellite Symposium Grand Ballroom Centre, 12:45 13:45 Children and Diabetes Technology a Challenging Constellation? Chair: Ewa Pańkowska (Poland) Modifying the course of Type 1 Diabetes in young people: opportunities for change Chair: Lori Laffel (USA) Technology and Teen: Make It Carefree, Comfortable, Concealed and Cool. Why don t teenagers use the technological advances available to them? Jill Weissberg-Benchell (USA) Easy as ABC? Clinical impact of automated bolus calculators in children. Results from the BABE study Ralph Ziegler (Germany) Welcome and introduction Lori Laffel (USA) Improving day-to-day care of T1D youth: opportunities and advancements Thomas Danne (Germany) Integrating effective management of exercise in T1D youth: from evidence-based data to real-life situations Michael Riddell (Canada) Eeny, meeny, miny, moe? Special accuracy requirements for insulin pumps by low insulin needs in children narrow the choice of viable systems or require alternative solutions Peter Adolfsson (Sweden) Optimizing glycemic control and diabetes-related quality of life in T1D youth: insights from the global TEENs study Barbara Anderson (USA) Questions and answers Panel Chair s summary Lori Laffel (USA) 11

12 Diversity in Diabetes Industry Satellite Symposia Thursday, September 4, 2014 Friday, September 5, 2014 Eli Lilly Satellite Symposium Grand Ballroom Centre, 17:00 18:30 Medtronic Satellite Symposium Grand Ballroom Centre, 12:45 13:45 Aptitudes and attitudes for a successful transition of care Chair: Cheril Clarson (Canada) Welcome and Introduction Cheril Clarson (Canada) Understanding the Young Adult Experience: Insights from the College Diabetes Network Christina Roth (USA) Impact of Sensor Augmented Pumps in real life to optimize patient s outcomes Chair: Carine de Beaufort (Luxembourg) Big data insights on CGM with Low Glucose Suspend Ram Weiss (Israel) Practical keys to successful CGM Margaret Lawson (Canada) Unique Issues and Challenges Sarah Lyons (USA) Creating a positive transition experience Jean-Francois Yale (Canada) Closing remarks Cheril Clarson (Canada) Dexcom Technology Workshop Meeting Room: Pine (Mezzanine Level), 17:00 18:30 Limited numbers only Practical Experience with Real Time Continuous Glucose Monitoring Chair: Peter Adolfsson (Sweden) The objectives of the program are: Provide hands-on experience with Dexcom G4 PLATINUM CGM System Discuss practical use and tips for Dexcom CGM with adult and pediatric users and case studies on CGM interpretation Review the current environment for CGM coverage and payment Introduce CGM technology future advancements and progress toward the artificial pancreas 12

13 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Exhibition Overview Exhibition Area Lower Concourse Poster Exhibition Session Session Room Room Grand Grand Ballroom Ballroom West Centre Session Room Grand Ballroom East Exhibition Area Access to Poster Exhibition Access to Session Rooms Coffee/ Lunch Break Exhibitors List 3 Roche Diagnostics 8 Eli Lilly and Company 4 Dexcom 9 BD Medical 5 Animas 10 Sanofi Diabetes 6 Medtronic 7 Novo Nordisk Merck (Merck Sharp & Dohme a subsidiary of Merck & Co., Inc.) International Society for Pediatric and Adolescent Diabetes 13

14 Proven Stellar Results Join Medtronic Exclusive Symposium at ISPAD Impact of Sensor Augmented Pumps in real life to optimize patient s outcomes Friday 5th September 12:45-13:45 in room Grand Ballroom Centre Dr Carine de Beaufort Luxembourg Prof. Ram Weiss Israel Dr Margaret Lawson Canada Chair Big Data insights on CGM with Low Glucose Suspend Practical keys to successful CGM

15 Discover Medtronic Innovation Village......and discuss the technologies of the future with our experts Innovation village situated in the Sheraton Center Toronto Room: Willow East Visit the Medtronic Booth n 6 UC EN Registration required to join one of the visits

16 Aptitudes and Attitudes fo ra Successful Transition of Ca re Room: Grand Ballroom Cen tre Date / Time: 4th September, 17:00-18:30 Conference Venue: Sherat on Centre, Toronto, Canada Agenda 17:00 Welcome and Introduction Cheril Clarson, Canada 17:05 Understanding the Young Adult Experience: Insights from the College Diabetes Network Christina Roth, USA 17:20 Unique Issues and Challe nges Sarah Lyons, USA 17:50 Creating a Positive Transi tion Experience Jean-Francois Yale, Canada 18:20 Closing Remarks Cheril Clarson, Canada

17 Modifying the course of Type 1 Diabetes in young people: opportunities for change , Thursday 4 September 2014 Ballroom Centre, Sheraton Centre, Toronto Chair: Lori Laffel Join our expert faculty for practical discussions on how to improve management and quality of life in young people with Type 1 Diabetes (T1D) Welcome and introduction Lori Laffel (USA) Improving day-to-day care of T1D youth: opportunities and advancements Thomas Danne (Germany) Integrating effective management of exercise in T1D youth: from evidence-based data to real-life situations Michael Riddell (Canada) Optimizing glycemic control and quality of life in T1D youth: insights from the global TEENs study Barbara Anderson (USA) Questions and answers Panel This information is provided for scientific purposes only. The views expressed are those of the individual authors and do not necessarily reflect the views of Sanofi. Sanofi does not recommend the use of any of its products in any manner inconsistent with that described in the full prescribing information available in your country. Before prescribing the product always refer to the prescribing information available in your country.

18 Diversity in Diabetes Exhibitor Profiles In alphabetical order Booth # 5 Animas Corporation 200 Lawrence Dr, West Chester, PA 19380, USA Animas, a member of the Johnson & Johnson Diabetes Solutions Companies, develops world class insulin pump technology designed to help patients perform at their best. From the beginning, our focus has been on advancing both the clinical and practical aspects of pump therapy, providing features for fine-tuned control, ease of use and lifestyle flexibility. Stop by our booth to find out what s behind our drive for performance and meet the OneTouch Ping insulin pump and meterremote, and the new Animas Vibe - the first insulin pump integrated with Dexcom G4 continuous glucose monitoring technology. Bayer HealthCare 100 Bayer Boulevard, P.O. Box 915, Whippany, New Jersey 07981, USA The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG is one of the world s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. For more information, please visit Booth # 9 BD Medical 1 Becton Drive, Franklin Lakes,NJ USA BD Medical Diabetes Care: For nearly 90 years, BD s culture of innovation and continuous improvement has enhanced the patient experience to enable better diabetes therapy and outcomes. BD Pen Needles and Insulin Syringes are designed with leading technology to support earlier initiation and better adherence to injectable therapies, helping diabetes patients live healthier lives. 18

19 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Exhibitor Profiles Booth # 4 Dexcom, Inc Sequence Drive, San Diego, CA 92121, USA Dexcom, Inc. develops and markets continuous glucose monitoring systems for use by diabetes patients as well as professional CGM for real-time feedback and insights for clinicians. The Dexcom G4 PLATINUM CGM is the only CGM approved for patients as young as 2 years old. Accuracy coupled with lifestyle-oriented features have users consistently ranking Dexcom highest in customer satisfaction and loyalty. For more information, visit Booth # 8 Eli Lilly and Company Lilly Corporate Center, Indianapolis, IN 46285, USA Lilly has been a global leader in diabetes care since 1923, when we introduced the world s first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio, and a continued commitment to providing real solutions from medicines to support programs and more to make lives better. We welcome you to ISPAD. Hyperion Therapeutics, Inc Sierra Point Parkway, Brisbane, California, 94005, USA HYPERION THERAPEUTICS, INC. is a biopharmaceutical company focused on advancing the treatment of adult and pediatric patients with serious metabolic and endocrine disorders. With two therapeutic products currently on the market and another in Phase III, we give hope to patients and their caregivers, every day. 19

20 Diversity in Diabetes Exhibitor Profiles Booth # 12 International Society for Pediatric and Adolescent Diabetes c/o K.I.T. Group, Kurfürstendamm 71, Berlin, Germany Globally, diabetes is a disease in evolution affecting more and more children and adolescents. ISPAD is a professional organization whose aims are to promote clinical and basic science, research, education and advocacy in childhood and adolescent diabetes. The strength of ISPAD lies in the scientific and clinical expertise in childhood and adolescent diabetes of its members. ISPAD is the only international society focusing specifically on all types of childhood diabetes. All forms of diabetes treatment in childhood should be based upon scientific evidence or clinical consensus. Parents are urged to contact their doctor regarding any type of treatment to take part of the evidence for it. Booth # 6 Medtronic International Trading Sàrl Rte du Molliau 31, 1131 Tolochenaz, Switzerland As a global leader in medical technology, Medtronic ( is committed to Innovating for Life by pushing the boundaries of medical technology and actually changing the way the world treats chronic disease. Driven by our deep understanding of the human body and our close partnerships with physicians, we re transforming technology to treat patients across the entire care continuum. Medtronic Diabetes offers advanced diabetes therapies including external pumps and infusion sets for insulin delivery and glucose sensing devices for both retrospective and continuous glucose monitoring. By combining insulin pump technology and glucose sensing technology, an important step in delivering the artificial pancreas, Medtronic Diabetes is well placed to distinguish itself as a global leader in diabetes care Booth # 11 Merck (Merck Sharp & Dohme a subsidiary of Merck & Co., Inc.) One Merck Drive, P.O. Box 100, Whitehouse Station, NJ USA Stop by to learn how you can be part of research supporting pediatric type 2 diabetes mellitus, phase 3 clinical trials. 20

21 40 th Annual Conference International Society for Pediatric and Adolescent Diabetes Exhibitor Profiles Booth # 7 Novo Nordisk Novo Alle, 2880 Bagsvaerd, Denmark Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries. Novo Nordisk s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com. Booth # 3 Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, Germany Roche Diabetes Care is a global market leader providing innovative solutions for personalized diabetes management. The Accu- Chek portfolio encompasses smart blood glucose meters like the Accu-Chek Mobile or the Accu-Chek Aviva Expert system and interactive insulin delivery systems as the Accu-Chek Insight system. Plus, cloud-based diabetes management solutions like the Accu-Chek Connect system which includes a blood glucose meter that wirelessly talks to a mobile app and lets caregivers and people with diabetes exchange important therapy data via a web portal supporting both in optimally managing the condition and facilitate informed therapy decisions - leading to an improved outcome. Booth # 10 Sanofi Diabetes 54 Rue de la Boétie, Paris, France Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services and devices, including intelligent blood glucose monitoring systems. Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes. 21

22 TYPE 1 BETA CELLS. PRESERVING THEM IS CRITICAL FOR PATIENTS AND CENTRAL TO OUR RESEARCH. Preventing beta cell loss is an important area of research we re currently conducting in patients with new-onset Type 1 diabetes. To find out more, contact us at T1D@hyperiontx.com HYPERION THERAPEUTICS, INC. is a biopharmaceutical company focused on advancing the treatment of adult and pediatric patients with serious metabolic and endocrine disorders. With two therapeutic products currently on the market and another in Phase III, we give hope to patients and their caregivers, every day. Hyperion Therapeutics, Inc. 200 Sierra Point Parkway, Suite 400, Brisbane, California hyperiontx.com P

23 New Accu-Chek solutions for you The Accu-Chek Connect diabetes management system Better connected for better decisions The Accu-Chek Insight diabetes therapy system Designed with your patients lives in mind Visit us in the Exhibition area at booth 3 and find out more Experience what s possible. For more information about Accu-Chek, visit ACCU-CHEK, ACCU-CHEK AVIVA CONNECT, ACCU-CHEK AVIVA INSIGHT, ACCU-CHEK CONNECT and ACCU-CHEK INSIGHT are trademarks of Roche Roche Diagnostics Roche Diagnostics GmbH Sandhofer Str. 116 D Mannheim

24